Literature DB >> 31275658

Comment on "Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer".

Gianluca Franceschini1, Alba Di Leone1, Riccardo Masetti1.   

Abstract

Entities:  

Year:  2019        PMID: 31275658      PMCID: PMC6582877          DOI: 10.1155/2019/4693794

Source DB:  PubMed          Journal:  Int J Breast Cancer        ISSN: 2090-3189


× No keyword cloud information.
We read with interest the work of Chaitanyanand Koppiker and colleagues [1] and would like to add some useful suggestions to improve oncological and cosmetic outcomes. Extreme oncoplastic surgery (EOS) is a breast conserving operation, using oncoplastic techniques, in a patient who requires a mastectomy. It is a promising new concept in the multidisciplinary treatment of selected patients with generally large, greater than 5 cm multifocal or multicentric tumor desiring breast conservation [2-4]. These oncoplastic techniques allow the resection of a greater amount of breast tissue with safer margins and acceptable aesthetic results increasing breast conservation rates [5-8]. The indications for EOS are different and various algorithms have been devised to assist with the decision process [3-5]. Long-term data on recurrence and survival are not available, using this approach. It is expected that the local recurrence will be somewhat higher but that there will be little or no impact on survival [3, 9]. Chaitanyanand Koppiker and colleagues conclude in their study that “Extreme Oncoplastic Surgery followed by RT results in acceptable local-regional control, low rate of complications, and high patient satisfaction. In selected patients, EO could provide a safe alternative for breast conservation surgery instead of mastectomy” [1]. However, a “great surgical hand” in EOS is not enough to optimize the oncological and aesthetic results! We think that a good oncoplastic surgery requires both individual ability and technical skill but also other attributes as dedication, decision-making skills, and the repetitive performance of specific tasks. So, while performing the extreme oncoplastic breast conserving surgery, the modern oncoplastic surgeon should always follow some specific and crucial steps, such as careful local staging of the disease with ultrasonography, mammography, and magnetic resonance before surgery; adequate radiological preoperative study with localization of tumor and/or calcifications; multidisciplinary discussion, in a dedicated “surgery board”, to choose an oncoplastic technique tailored to patient; intraoperative ultrasound to guide the resection; intraoperative radiological and pathological evaluation of the specimen for definition of lesion and margins of resection; frozen sections should be obtained from a portion of all six faces of the resected specimen; systematic circumferential tumor cavity shaving to have a backup to lumpectomy margins; placement of clips within the excision cavity as a “landmark” to define the tumor bed and guide adjuvant breast radiotherapy; accurate pathological assessment of the specimen using macrosections. This multidisciplinary path leads more easily to tumor-free margins by keeping the amount of healthy breast tissue excision as low as possible; while performing oncoplastic procedures, it would be useful to bear in mind these recommendations and suggestions in order to improve oncological and cosmetic outcomes. The modern breast surgeon must always know where they are going and the repetitive performance of specific tasks could enhance their ability when faced with the extreme and complex oncoplastic procedures.
  8 in total

1.  Radical Mastectomy to Radical Conservation (Extreme Oncoplasty): A Revolutionary Change.

Authors:  Melvin J Silverstein
Journal:  J Am Coll Surg       Date:  2016-01       Impact factor: 6.113

2.  First international consensus conference on standardization of oncoplastic breast conserving surgery.

Authors:  Walter P Weber; Savas D Soysal; Mahmoud El-Tamer; Virgilio Sacchini; Michael Knauer; Christoph Tausch; Nik Hauser; Andreas Günthert; Yves Harder; Elisabeth A Kappos; Fabienne Schwab; Florian Fitzal; Peter Dubsky; Vesna Bjelic-Radisic; Roland Reitsamer; Rupert Koller; Jörg Heil; Markus Hahn; Jens-Uwe Blohmer; Jürgen Hoffmann; Christine Solbach; Christoph Heitmann; Bernd Gerber; Martin Haug; Christian Kurzeder
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

Review 3.  Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery.

Authors:  Madeleine C Strach; Thiru Prasanna; Youlia M Kirova; Severine Alran; Sandra O'Toole; Jane M Beith; Philip Poortmans; Catriona M McNeil; Susan Carroll
Journal:  Crit Rev Oncol Hematol       Date:  2018-11-30       Impact factor: 6.312

4.  Extreme oncoplasty: Expanding indications for breast conservation.

Authors:  Angelena Crown; Ruby Laskin; Flavio G Rocha; Janie Grumley
Journal:  Am J Surg       Date:  2019-01-24       Impact factor: 2.565

Review 5.  Conservative and radical oncoplastic approches in the surgical treatment of breast cancer.

Authors:  G Franceschini; S Magno; C Fabbri; F Chiesa; A Di Leone; F Moschella; I Scafetta; A Scaldaferri; S Fragomeni; L Adesi Barone; D Terribile; M Salgarello; R Masetti
Journal:  Eur Rev Med Pharmacol Sci       Date:  2008 Nov-Dec       Impact factor: 3.507

Review 6.  Update on oncoplastic breast surgery.

Authors:  G Franceschini; D Terribile; S Magno; C Fabbri; C Accetta; A Di Leone; F Moschella; R Barbarino; A Scaldaferri; S Darchi; M E Carvelli; S Bove; R Masetti
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-10       Impact factor: 3.507

7.  Extreme oncoplasty: breast conservation for patients who need mastectomy.

Authors:  Melvin J Silverstein; Nirav Savalia; Sadia Khan; Jessica Ryan
Journal:  Breast J       Date:  2015-01-08       Impact factor: 2.431

8.  Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer.

Authors:  Chaitanyanand B Koppiker; Aijaz Ul Noor; Santosh Dixit; Laleh Busheri; Gautam Sharan; Upendra Dhar; Hari Kiran Allampati; Smeeta Nare
Journal:  Int J Breast Cancer       Date:  2019-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.